In this interview, Jesmond Dalli, PhD, focuses on effective therapeutic approaches for resolving joint inflammation and regeneration, while highlighting the shortcomings of some existing treatments. He details his latest research on the use of Maresins in treating rheumatoid arthritis patients and the clinical insights gained from this work. Dr. Dalli concludes by explaining how specialized pro-resolving mediators (SPMs) offer a novel approach to therapy and can complement standard pain management treatments.
Jesmond Dalli, PhD, is a Professor of Molecular Pharmacology at the Barts and The London School of Medicine and Dentistry and Queen Mary College.
From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana
